{"nct_id":"NCT01323621","title":"Study Evaluating the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","status_verified_date":"2018-01","start_date":"2011-03-18","start_date_type":null,"primary_completion_date":"2012-01-01","primary_completion_date_type":"ACTUAL","completion_date":"2012-01-24","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}